Hyperacute toxicity with combination ipilimumab (ipi) and anti-PD1 immunotherapy.
Helen Dearden, Lewis Au, Daniel Ying Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Curvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Alexander Guminski, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies (2018). Hyperacute toxicity with combination ipilimumab (ipi) and anti-PD1 immunotherapy.. , 36(15_suppl), DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.9545.
